SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-180866
Filing Date
2015-05-11
Accepted
2015-05-11 09:19:01
Documents
3
Period of Report
2015-05-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 2.06: Material Impairments
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d923280d8k.htm 8-K 37416
2 EX-10.1 d923280dex101.htm EX-10.1 865609
3 EX-10.2 d923280dex102.htm EX-10.2 53714
  Complete submission text file 0001193125-15-180866.txt   958329
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 15849123
SIC: 2834 Pharmaceutical Preparations